Missouri Trust & Investment Co Sells 200 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Missouri Trust & Investment Co trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,425 shares of the exchange traded fund’s stock after selling 200 shares during the period. Missouri Trust & Investment Co’s holdings in SPDR S&P Biotech ETF were worth $128,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund raised its position in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after purchasing an additional 18,202 shares during the last quarter. Mirae Asset Securities USA Inc. lifted its position in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares in the last quarter. Finally, Employees Retirement System of Texas boosted its holdings in SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9 %

Shares of XBI stock opened at $90.51 on Wednesday. The firm’s fifty day moving average price is $93.58 and its two-hundred day moving average price is $96.95. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $6.90 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.